Jubilant receives USFDA approval for two generic drugs

Drug firm Jubilant Life Sciences Ltd Friday said it has received approval from the US Food and Drugs Administration (USFDA) to market generic versions of GlaxoSmithKline`s anti-depressant Wellbutrin SR and smoking cessation aid, Zyban.